Recruiting Primary Biliary Cholangitis Studies in Tucson
About Primary Biliary Cholangitis Clinical Trials in Tucson
Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease in which the bile ducts in the liver are slowly destroyed. This leads to bile buildup, liver damage, and potentially cirrhosis. Treatment includes ursodeoxycholic acid and obeticholic acid.
There are currently 1 primary biliary cholangitis clinical trials recruiting participants in Tucson, ARIZONA. These studies are seeking a combined 276 participants. Research is being sponsored by Ipsen. Clinical trial participation is free and participants receive study-related medical care at no cost.
Primary Biliary Cholangitis Clinical Trials in Tucson — FAQ
Are there primary biliary cholangitis clinical trials in Tucson?
Yes, there are 1 primary biliary cholangitis clinical trials currently recruiting in Tucson, ARIZONA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Tucson?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you about next steps.
Are clinical trials in Tucson free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tucson studies also compensate for your time and travel.
What primary biliary cholangitis treatments are being tested?
The 1 active trials in Tucson are testing new therapies including novel drugs, biologics, and treatment approaches for primary biliary cholangitis.
Data updated March 2, 2026 from ClinicalTrials.gov